Previous Article | Next Article 
Infection and Immunity, July 2001, p. 4424-4429, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4424-4429.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Activation of Interleukin-1 Receptor-Associated
Kinase by Gram-Negative Flagellin
Marlena A.
Moors,1
Liwu
Li,2 and
Steven B.
Mizel1,*
Department of Microbiology and
Immunology1 and Section of Infectious
Diseases, Department of Internal Medicine,2 Wake
Forest University School of Medicine, Winston-Salem, North Carolina
27157
Received 25 January 2001/Accepted 2 April 2001
 |
ABSTRACT |
Flagellin from various species of gram-negative bacteria activates
monocytes to produce proinflammatory cytokines. We have analyzed the
pathway by which Salmonella enteritidis flagellin (FliC)
activates murine and human monocyte/macrophage-like cell lines. Since
lipopolysaccharide (LPS), the principal immune stimulatory component of
gram-negative bacteria, is known to signal through Toll-like receptor 4 (TLR4), we tested the possibility that FliC also signals via TLR4.
When murine HeNC2 cells were stimulated with LPS in the presence
of a neutralizing anti-TLR4 monoclonal antibody, tumor necrosis factor
alpha (TNF-
) and nitric oxide (NO) production were markedly reduced.
In contrast, FliC-mediated TNF-
and NO production were minimally
affected by the anti-TLR4 antibody. Furthermore, FliC, unlike LPS,
stimulated TNF-
production in the TLR4 mutant cell line, GG2EE,
indicating that TLR4 is not essential for FliC-mediated signaling. To
test the possibility that FliC signals via another TLR, we measured
FliC-mediated activation of interleukin-1 (IL-1) receptor-associated
kinase (IRAK), a central component in IL-1R/TLR signaling. FliC induced
IRAK activation in HeNC2 and GG2EE cells as well as in the human
promonocytic cell line THP-1. IRAK activation was
rapid in HeNC2 cells, with maximal activity observed after 5 min of
treatment with FliC. In addition, FliC-mediated IRAK
activation exhibited the same concentration dependence as was
demonstrated for the induction of TNF-
. These results
represent the first demonstration of IRAK activation by a purified
bacterial protein and strongly suggest that a TLR distinct from
TLR4 is involved in the macrophage inflammatory response to FliC.
 |
INTRODUCTION |
Activation of the innate immune
response by bacteria is mediated by a group of molecules that have
collectively been termed modulins (12). These
surface-associated molecules are produced by a broad array of microbial
pathogens and include lipopolysaccharide (LPS), peptidoglycan,
lipoteichoic acid, lipoarbinomannan, lipoproteins, and lipopeptides.
Monocytes and macrophages respond to modulins by producing
proinflammatory cytokines such as tumor necrosis factor alpha
(TNF-
), interleukin-1
(IL-1
), and IL-6 (12). The
production of cytokines is a critical event in the development of
protective innate immune responses and is also involved in the
initiation of adaptive immune responses. However, excessive production
of cytokines has also been implicated in the pathological events
associated with the septic response in patients with severe bacterial infections.
We and others have demonstrated that flagella from a number of
gram-negative bacterial species induce proinflammatory cytokine production by human monocytes and monocyte-like cell lines (7, 8,
35). Using genetic and biochemical approaches, it was demonstrated that the major structural protein of flagella, flagellin (FliC), was the component required for the induction of cytokine synthesis (7). In a subsequent study, it was found that
purified recombinant FliC from Salmonella enteriditis, Salmonella
enterica serovar Typhimurium, and
Pseudomonas aeruginosa were potent inducers of cytokine synthesis in human monocytes and THP-1 cells, a human promonocytic cell line (19). Half-maximal responses were
obtained with concentrations of FliC in the range of 15 to 30 pM.
Recently, it was reported that purified flagellin from
enteroaggregative Escherichia coli induces IL-8 production
by intestinal epithelial cells (28).
An important feature shared by many bacterial modulins is that they
signal monocytes and macrophages via proteins in the IL-1 receptor/Toll-like receptor (IL-1R/TLR) family (1).
Proteins in the IL-1R/TLR family are grouped based on conserved
sequences in their cytoplasmic domains that are required for signal
transduction (9, 10). Upon activation of the IL-1R and
TLRs several common events are triggered, including recruitment and
activation of the IL-1R-associated kinase (IRAK) via the adaptor
protein MyD88, formation of a complex between IRAK and TNF
receptor-associated factor 6, and activation of NF-
B and other
factors required for transcription of proinflammatory cytokine genes
(5, 20, 22, 33, 37). IL-1R/TLR family proteins belong to a
larger group of innate immune system receptors recently termed
pattern-recognition receptors (14). Pattern-recognition
receptor ligands, which include the previously mentioned
bacterial modulins, display molecular patterns unique to
microbial pathogens and have thus been termed PAMPs
(pathogen-associated molecular patterns). LPS, the prototype gram-negative PAMP, requires TLR4 to exert its biological effects (6, 13, 23, 24), whereas a diverse group of PAMPs
including gram-positive lipoteichoic acid and peptidoglycan
(25), lipoproteins and lipopeptides from various bacterial
species (3, 18, 30), and mycobacterial lipoarabinomannan
(31) appear to require TLR2. To date, at least 10 different TLR proteins have been described, suggesting the existence of
additional TLR ligands.
In view of the involvement of TLRs in signaling by LPS and other PAMPs,
we explored the possibility that FliC, a gram-negative bacterial
protein, might also utilize a TLR to exert its biological effects. Our
results indicate that FliC does utilize a Toll-like receptor signaling
pathway as demonstrated by its ability to activate IRAK. However, FliC
does not require TLR4, suggesting that an additional TLR(s) is
important in the innate response to gram-negative bacteria.
 |
MATERIALS AND METHODS |
Cell culture and biological reagents.
The C3H/HeN-derived
macrophage cell line HeNC2 (15) was kindly provided by A. Ding (Cornell University Medical College, New York, N.Y.). The
C3H/HeJ-derived macrophage cell line GG2EE (4) was
obtained from G. Cox (National Cancer Institute, Frederick, Md.). THP-1
cells were purchased from the American Type Culture Collection
(Rockville, Md.). Cells were grown in RPMI 1640 supplemented with 10%
fetal bovine serum, glutamine, and 50 µg of gentamicin/ml (complete
medium). The monoclonal antibody MTS510, which recognizes murine TLR4
in complex with MD-2 (2), was generously provided by
Kensuke Miyake (Department of Immunology, Saga Medical School, Nabeshima, Saga, Japan). Monoclonal antibody 3ZD, which recognizes murine and human IL-1
(16), was obtained from the
National Cancer Institute Biological Response Modifiers Repository.
Polyclonal anti-IRAK antibody was obtained from Upstate Biotechnology
Corp. Purified recombinant FliC from S. enteriditis was
prepared as previously described (19). LPS was removed
from FliC preparations by passage through a polymyxin B column
according to the manufacturer's instructions (Detoxi-Gel; Pierce
Chemical Co.). Salmonella serovar Typhimurium LPS was
obtained from Sigma Chemical Co.
Induction and measurement of TNF-
and NO production.
Cells were seeded in 24-well tissue culture dishes at 106
cells/ml in complete medium containing the indicated concentrations of
FliC. After 24 or 48 h, the level of TNF-
or nitric oxide (NO)
produced was determined. TNF-
levels in culture supernatants of
HeNC2 and GG2EE cells were measured using a commercial enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Inc., Minneapolis, Minn.). In the experiments with THP-1 cells, 0.5% Triton X-100 was
added to each culture and the total TNF-
content (cell associated and released) was measured using a commercial ELISA kit (Abraxis, Hatboro, Pa.). The production of NO by murine cell lines was determined by measuring NO2
in culture supernatants as
previously described (15).
IRAK assay.
IRAK activity in cell lysates was measured as
previously described (17) using [
32P]ATP
and myelin basic protein as a substrate. Reaction products were subject
to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the
bands were visualized by autoradiography. The intensity of
32P-labeled myelin basic protein bands was quantitated
using a Molecular Dynamics phosphorimaging system. IRAK protein was
detected by Western blotting using polyclonal anti-IRAK antibody.
 |
RESULTS |
Activation of HeNC2 cells by FliC.
As a first step in the
analysis of the FliC signaling mechanism, we evaluated the effect of
recombinant FliC on TNF-
and NO production by HeNC2 cells. To ensure
that we would be measuring responses induced by FliC and not
contaminating LPS, a polymyxin B resin was used to remove LPS. This
treatment reduced the LPS content of the FliC preparation from
approximately 20 µg/ml to 1 ng/ml as measured by the
Limulus amebocyte assay. Since the concentration of the FliC
stock preparation was in the range of 10
6 M and the
concentrations used for assays were in the range of 10
12
to 10
9 M, the maximal level of LPS in the cultures was
less than 1 pg/ml. At this concentration, LPS had little if any effect
in our assays.
Like human monocytes and THP-1 cells (19), HeNC2 cells
were extremely sensitive to stimulation by FliC. As shown in Fig. 1, TNF-
and NO production were
maximally stimulated at concentrations below 10
9 M. Generally, 50% of the maximal response was achieved with FliC concentrations in the range of 10 to 40 pM.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
FliC-induced activation of HeNC2 cells. HeNC2 cells were
cultured with increasing concentrations of FliC. (A) TNF- in culture
supernatants was measured after 24 h by ELISA. The amount of
TNF- produced in unstimulated control cultures was subtracted from
each value. Similar results were obtained in three independent
experiments. (B) NO production was assessed after 48 h by
measuring the amount of nitrite, a stable byproduct of NO. The values
represent the mean of duplicate determinations (standard deviation,
<5%) from two independent experiments.
|
|
FliC-induced macrophage activation does not require TLR4.
In
view of the critical role of TLR4 in the innate immune response to
gram-negative bacteria (23, 24), we tested the possibility that S. enteriditis FliC might, like LPS, utilize a
TLR4-dependent signaling pathway to activate macrophages. Thus, HeNC2
cells were incubated with FliC in the presence and absence of a
neutralizing anti-murine TLR4 monoclonal antibody (MTS510) that blocks
LPS-induced cytokine production in murine macrophages (2).
Although MTS510 markedly reduced TNF-
and NO production in response
to LPS (55 and 70% inhibition, respectively), it had little effect on
FliC-induced production of these mediators; the effect of MTS510 on
FliC activity was not reproducibly different than that obtained with
the control monoclonal antibody, 3ZD (Fig.
2 and data not shown). These results indicate that in contrast to LPS, FliC does not appear to utilize a
TLR4-dependent pathway. However, we felt that it was important to use
an additional approach to strengthen the experimental basis for this
conclusion. Therefore, we tested the effect of FliC on GG2EE cells.
This macrophage cell line was derived from the C3H/HeJ mouse and
exhibits the same phenotype of LPS hyporesponsiveness that is due to a
mutation in the TLR4 gene (13, 23, 24). As shown in Fig.
3, GG2EE cells produced TNF-
in
response to FliC, with 50% of the maximal response observed at
approximately 10
10 M FliC. As previously reported
(15), LPS at 1 ng/ml failed to stimulate significant
TNF-
production by GG2EE cells (135 ± 71 pg/ml; n = 3). In conjuction with results obtained with the anti-TLR4
monoclonal antibody, the data presented in Fig. 3 provide strong
evidence that TLR4 is not required for FliC-induced signal transduction.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 2.
Anti-TLR4 monoclonal antibody does not block the
stimulatory effect of FliC. HeNC2 cells were cultured in the presence
of 3 × 10 11 M FliC with no antibody added (open
bars), with 20 µg of anti-IL-1 antibody 3ZD/ml (gray bars), or
with 20 µg of anti-TLR4 antibody MTS510/ml (black bars). (A) TNF-
production after 24 h. (B) NO production after 48 h. The
values represent the mean of duplicate determinations (standard
deviation, <5%). Similar results were obtained in three independent
experiments. The percent inhibition relative to controls in which no
antibody was added is indicated in parentheses.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
FliC induces TNF- production in LPS-hyporesponsive
GG2EE cells. GG2EE cells were cultured with the indicated
concentrations of FliC for 24 h. The amount of TNF- in culture
supernatants was measured by ELISA. Similar results were obtained in
three independent experiments.
|
|
FliC induces IRAK activation.
Although our results do not
support a role for TLR4 in FliC signaling, it was still possible that
FliC utilizes another TLR. To test this possibility, we measured the
activation of IRAK, a central component in TLR signaling, in response
to FliC. The murine macrophage-like cell lines HeNC2 and GG2EE were
incubated with or without FliC for 15 min, and the level of IRAK
catalytic activity (as measured by phosphorylation of the synthetic
substrate myelin basic protein) as well as IRAK protein expression was
measured. For comparative purposes, another set of cultures was
stimulated with LPS. As shown in Fig. 4B,
FliC induced a very pronounced increase in IRAK activity in GG2EE and
HeNC2 cells (lanes 2 and 5) relative to unstimulated cells (lanes 1 and
4). In contrast, LPS (1 ng/ml) had no effect on the LPS-hyporesponsive
GG2EE cells but did induce significant IRAK activity in the
LPS-responsive HeNC2 cells (lanes 3 and 6). Kinase activity
correlated with a decrease in the size of the 80-kDa IRAK band and
the appearance of a more slowly migrating species (Fig. 4A, lanes 2, 5, and 6). The latter band presumably is phosphorylated IRAK. Since
phosphorylated IRAK is rapidly degraded, this form of the protein is
detected at reduced levels relative to the unactivated protein
(36). In each case, the activation of IRAK corresponded
with the production of TNF-
(Fig. 4C).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 4.
FliC activates IRAK in HeNC2 and GG2EE cells. HeNC2 and
GG2EE cells (107 cells per sample) were cultured in the
absence (lanes 1 and 4) or presence of 10 9 M FliC (lanes
2 and 5) or 1 ng of LPS/ml (lanes 3 and 6) for 15 min at 37°C. (A)
IRAK was immunoprecipitated (IP) from cell lysates using anti-IRAK
antibody, and the protein was visualized by Western blotting using the
same antibody. (B) IRAK kinase activity in the same cell lysates was
measured by in vitro kinase assay using myelin basic protein as a
substrate (MBP-P). The fold induction of IRAK activity relative to the
unstimulated control is indicated below each lane. (C) TNF-
production in culture supernatants after 24 h. Similar results
were obtained in three independent experiments.
|
|
Recently, Li et al. demonstrated that IRAK is activated by LPS in the
human promonocytic cell line THP-1 and that the response is maximal
after approximately 60 min (17). To determine if FliC also
activates IRAK in human cells, we incubated THP-1 cells in the presence
or absence of FliC for 60 min prior to measuring IRAK activity and
protein expression. The level of TNF-
was also measured after
culturing the cells for 24 h. As shown in Fig. 5, FliC activated IRAK in THP-1 cells in
a concentration-dependent manner. A complete dose-response curve is
shown in Table 1. As with the murine
cells, the appearance of a more slowly migrating species of IRAK was
detected in samples exhibiting significant kinase activity (Fig. 5,
lanes 3 and 4 versus lane 1).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
FliC activates IRAK in the human promonocytic THP-1 cell
line. THP-1 cells (5 × 106 cells per sample) were
cultured for 1 h in the absence (lane 1) or presence of
10 11 M FliC (lane 2), 10 10 M FliC (lane 3),
or 10 9 M FliC (lane 4). (A) Western blot of IRAK
expression. (B) IRAK kinase activity. Similar results were obtained in
three independent experiments.
|
|
Kinetics of FliC-induced IRAK activation.
Swantek et al.
recently reported that LPS activates IRAK in murine peritoneal
macrophages within 7.5 min of treatment (29). Similar to
the effect of LPS, the activation of IRAK in response to FliC was quite
rapid. Maximal kinase activity was observed after 5 min of treatment
and decreased steadily thereafter (Fig. 6). By 60 min, the level of kinase
activity was only slightly above the level detected in cultures of
unstimulated cells. Time course experiments with THP-1 cells also
revealed a rapid induction of IRAK, with significant kinase activity
observed within 5 min of the addition of FliC (data not shown).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 6.
Time course of FliC-induced IRAK activation in HeNC2
cells. (A) HeNC2 cells (107 cells per sample) were cultured
in the absence or presence of 10 9 M FliC. Cultures with
FliC added were prepared in duplicate. Cells were lysed at the
indicated time points, and IRAK activity was measured by in vitro
kinase assay. (B) Fold induction of IRAK activity relative to
unstimulated controls.
|
|
 |
DISCUSSION |
Our results demonstrate that FliC is a potent stimulant for murine
and human monocytes and macrophages. Half-maximal stimulation of
cytokine and NO production occurs with concentrations of FliC in the pM
range (Fig. 1) (19). Furthermore, our results indicate that similar concentrations of FliC induce a very rapid and marked increase in IRAK activity (Fig. 4 to 6), providing an important insight
into the mechanism by which FliC exerts its effect on macrophages.
IRAK is a central component of the signal transduction pathway
triggered upon activation of IL-1R/TLR family proteins (20, 33). In IL-1-responsive cells, IRAK is recruited to the type 1 IL-1R, multiphosphorylated, and almost completely degraded within 10 min of treatment with IL-1 (36). In mouse peritoneal
macrophages, IRAK activity is detected within 7.5 min of treatment with
LPS and declines rapidly after 15 min (29). Similarly, we
showed that FliC activates IRAK catalytic activity in murine
macrophages rapidly, with peak activity observed after 5 min of
treatment. It was recently found that FliC induces a substantial
increase in TNF-
mRNA levels in THP-1 cells within 15 min after
addition to monocytic cells (F. Ciacci-Woolwine and S. B. Mizel, unpublished observations). Thus the observation that FliC
activates IRAK within 5 min is consistent with the hypothesis that this
process is a critical step in a signaling cascade that results in the
relatively rapid expression of proinflammatory cytokines.
As demonstrated previously for LPS (17) and IL-1
(36), we observed a reduction in the level of the 80-kDa
IRAK protein coincident with the appearance of a weak, more slowly
migrating species in lysates of cells which exhibited significant in
vitro kinase activity (see Fig. 4). The appearance of a higher
molecular weight species of IRAK in response to IL-1 stimulation was
shown to be the result of IRAK phosphorylation (36). It
was further demonstrated that phosphorylated IRAK is rapidly degraded
in IL-1-stimulated cells (36). Although not a formal
demonstration, our results suggest that as documented for LPS and IL-1,
transmission of a signal by FliC involves phosphorylation and
degradation of IRAK.
Since IRAK activation is a hallmark of the signal transduction pathway
linked to the Toll-like receptor family of proteins, our results
strongly suggest that FliC signals macrophages via a TLR. To date, a
diverse group of bacterial cell surface molecules (PAMPs) has been
shown to signal macrophages via TLRs. LPS, the prototype bacterial
PAMP, requires TLR4 for signal transduction (23, 24). TLR2
is the receptor utilized by gram-positive lipoteichoic acid and
peptidoglycan (25), mycobacterial lipoarabinomannan (31), and a wide array of lipoproteins and lipopeptides
(3, 18, 30). The latter group of PAMPs has been shown to
require the N-terminal lipid moiety for biologic activity
(12). In addition, it was reported recently that TLR9 is
the receptor that transduces a signal in response to bacterial DNA
(11). In view of the available data regarding TLR ligands,
our results demonstrating that recombinant, LPS-free FliC activates
IRAK are of particular importance, as no study to date has reported the
activation of a TLR signaling pathway by a purified bacterial protein.
Given that at least 10 distinct TLRs have been described to date, and
due to limited reagent availability for most of these proteins,
identification of the specific TLR utilized by FliC was beyond the
scope of the present study. However, a neutralizing anti-TLR4
monoclonal antibody inhibited LPS-induced TNF-
and NO production by
HeNC2 cells but had little effect on FliC-induced responses,
suggesting that FliC signals through a TLR other than TLR4.
Furthermore, in direct contrast to the effects of LPS, FliC induced the
activation of IRAK and TNF-
production in C3H/HeJ-derived GG2EE
cells. These results further substantiate the conclusion that FliC
utilizes a signaling receptor that is distinct from TLR4, the receptor
utilized by LPS. The possibility that FliC mediates its effects via
TLR2 seems unlikely as it does not appear that TLR2 is involved in the
innate response to gram-negative bacteria. Specifically, it was
recently demonstrated that expression of a dominant negative mutant of
TLR2 in murine macrophages inhibited TNF-
production in response to
Staphylococcus aureus and gram-positive cell wall products
but not in response to Salmonella serovar Minnesota or LPS
(32). Interestingly, however, Sebastiani et al. have mapped a Salmonella-susceptibility locus on murine
chromosome 1 to a region containing the tlr5 gene
(26). Thus, TLR5, which like TLR4 and TLR2 is expressed by
myelomonocytic cells (21), is a candidate receptor for
FliC. Clearly, additional studies will be necessary to identify the
receptor(s) that participates in FliC-mediated signaling. In any case,
our data suggest that in addition to TLR4, another TLR(s) is likely to
be important in the recognition of gram-negative bacteria by cells of
the innate immune response. In this regard, it will also be of interest
to determine if, like LPS, FliC requires an initial binding receptor analogous to CD14 (34) or if FliC directly interacts with
a TLR. The latter scenario has yet to be demonstrated for any TLR studied to date. Since CD14-negative U937-derived U38 cells respond to
flagella (8), it is unlikely that CD14 is involved in the response to FliC.
The effects of FliC on macrophages are quantitatively and
qualitatively similar to the well-documented effects of LPS,
suggesting that gram-negative flagellin is likely to play an
important and previously unrecognized role in the innate immune
response to gram-negative bacteria. Since intact flagella (8,
35) as well as the released soluble form of flagellin (7,
19) are active, it is likely that this bacterial modulin
may contribute to localized as well as disseminated responses to
gram-negative pathogens. FliC may be of particular importance during
the course of infections in the gastrointestinal tract, since
lamina propria macrophages in the intestinal mucosa do not
express CD14 and are LPS nonresponsive (27).
Nevertheless, gram-negative enteric pathogens such as
Salmonella serovar Enteriditis induce cytokine production
and inflammation in the intestinal mucosa. Future studies directed at
identifying the surface receptor(s) for FliC and further characterizing
the intracellular events triggered by the interaction of FliC with
macrophages should provide important insights into the mechanisms
by which gram-negative bacteria activate innate immunity.
 |
ACKNOWLEDGMENTS |
This work was supported by National Institutes of Health grant
AI-38670 (to S.B.M) and by the Signal Transduction Mechanisms and Cell
Function training program, grant CA-09422, from the National Institutes
of Health (M.A.M).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, NC 27157. Phone: (336) 716-2216. Fax: (336) 716-9928. E-mail: smizel{at}wfubmc.edu.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Aderem, A., and R. J. Ulevitch.
2000.
Toll-like receptors in the induction of the innate immune response.
Nature
406:782-787[CrossRef][Medline].
|
| 2.
|
Akashi, S.,
R. Shimazu,
H. Ogata,
Y. Nagai,
K. Takeda,
M. Kimoto, and K. Miyake.
2000.
Cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages.
J. Immunol.
164:3471-3475[Abstract/Free Full Text].
|
| 3.
|
Aliprantis, A. O.,
R. Yang,
M. Mark,
S. Sugget,
B. Devaux,
J. D. Radolf,
G. R. Klimpel,
P. Godowski, and A. Zychlinsky.
1999.
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor 2.
Science
285:736-739[Abstract/Free Full Text].
|
| 4.
|
Blasi, E.,
D. Radzioch,
S. K. Durum, and L. Varesio.
1987.
A murine macrophage cell line, immortalized by v-raf and v-myc oncogenes, exhibits normal macrophage functions.
Eur. J. Immunol.
17:1491-1498[Medline].
|
| 5.
|
Cao, Z.,
J. Xiong,
M. Takeuchi,
T. Kurama, and D. V. Goeddel.
1996.
TRAF6 is a signal transducer for interleukin-1.
Nature
383:443-446[CrossRef][Medline].
|
| 6.
|
Chow, J. C.,
D. W. Young,
D. T. Golenbock,
W. J. Christ, and F. Gusovsky.
1999.
Toll-like receptor 4 mediates lipopolysaccharide-induced signal transduction.
J. Biol. Chem.
274:10689-10692[Abstract/Free Full Text].
|
| 7.
|
Ciacci-Woolwine, F.,
I. C. Blomfield,
S. H. Richardson,
N. P. Iyer, and S. B. Mizel.
1998.
Salmonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line.
Infect. Immun.
66:1127-1134[Abstract/Free Full Text].
|
| 8.
|
Ciacci-Woolwine, F.,
P. F. McDermott, and S. B. Mizel.
1999.
Induction of cytokine synthesis by flagella from gram-negative bacteria may be dependent on the activation or differentiation state of human monocytes.
Infect. Immun.
67:5176-5185[Abstract/Free Full Text].
|
| 9.
|
Gay, N. J., and F. J. Keith.
1991.
Drosophila Toll and IL-1 receptor.
Nature
351:355-356[Medline].
|
| 10.
|
Heguy, A.,
C. T. Baldari,
G. Macchia,
J. L. Telford, and M. Melli.
1992.
Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the Drosophila Toll protein are essential for IL-1R signal transduction.
J. Biol. Chem.
267:2605-2609[Abstract/Free Full Text].
|
| 11.
|
Hemmi, H.,
O. Takeuchi,
T. Kawai,
T. Kaisho,
S. Sato,
H. Sanjo,
M. Matsumoto,
K. Hoshino,
H. Wagner,
K. Takeda, and S. Akira.
2000.
A Toll-like receptor recognizes bacterial DNA.
Nature
408:740-745[CrossRef][Medline].
|
| 12.
|
Henderson, B.,
S. Poole, and M. Wilson.
1996.
Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.
Microbiol. Rev.
60:316-341[Abstract/Free Full Text].
|
| 13.
|
Hoshino, K.,
O. Takeuchi,
T. Kawai,
H. Sanjo,
T. Ogawa,
Y. Takeda,
K. Takeda, and S. Akira.
1999.
Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.
J. Immunol.
162:3749-3752[Abstract/Free Full Text].
|
| 14.
|
Janeway, C. A., Jr., and R. Medzhitov.
1998.
Introduction: the role of innate immunity in the adaptive immune response.
Semin. Immunol.
10:349-350[CrossRef][Medline].
|
| 15.
|
Jin, F.,
C. Nathan,
D. Radzioch, and A. Ding.
1997.
Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.
Cell
88:417-426[CrossRef][Medline].
|
| 16.
|
Lew, W.,
J. J. Oppenheim, and K. Matsushima.
1988.
Analysis of the suppression of IL-1alpha and IL-1beta production in human peripheral blood mononuclear adherent cells by a glucocortocoid hormone.
J. Immunol.
140:1895-1902[Abstract/Free Full Text].
|
| 17.
|
Li, L.,
S. Cousart,
J. Hu, and C. E. McCall.
2000.
Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells.
J. Biol. Chem.
275:23340-23345[Abstract/Free Full Text].
|
| 18.
|
Lien, E.,
T. J. Sellati,
A. Yoshimura,
T. H. Flo,
G. I. Rawadi,
R. W. Finberg,
J. D. Carroll,
T. Espevik,
R. Ingalls,
J. D. Radolf, and D. T. Golenbock.
1999.
Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.
J. Biol. Chem.
274:33419-33425[Abstract/Free Full Text].
|
| 19.
|
McDermott, P. F.,
F. Ciacci-Woolwine,
J. A. Snipes, and S. B. Mizel.
2000.
High-affinity interaction between gram-negative flagellin and a cell surface polypeptide results in human monocyte activation.
Infect. Immun.
68:5525-5529[Abstract/Free Full Text].
|
| 20.
|
Medzhitov, R.,
P. Preston-Hurlburt,
E. Kopp,
A. Stadlen,
C. Chen,
S. Ghosh, and C. A. Janeway, Jr.
1998.
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
Mol. Cell
2:253-258[CrossRef][Medline].
|
| 21.
|
Muzio, M.,
D. Bosisio,
N. Polentarutti,
G. D'amico,
A. Stoppacciaro,
R. Mancinelli,
C. Veer,
G. Penton-Rol,
L. P. Ruco,
P. Allavena, and A. Mantovani.
2000.
Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells.
J. Immunol.
164:5998-6004[Abstract/Free Full Text].
|
| 22.
|
Muzio, M.,
J. Ni,
P. Feng, and V. M. Dixit.
1997.
IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.
Science
278:612-615[CrossRef].
|
| 23.
|
Poltorak, A.,
X. He,
I. Smirnova,
M. Y. Liu,
C. Van Huffel,
X. Du,
D. Birdwell,
E. Alejos,
M. Silva,
C. Galanos,
M. Freudenberg,
P. Ricciardi-Castagnoli,
B. Layton, and B. Beutler.
1998.
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene.
Science
282:2085-2088[Abstract/Free Full Text].
|
| 24.
|
Qureshi, S. T.,
L. Lariviere,
G. Leveque,
S. Clermont,
K. J. Moore,
P. Gros, and D. Malo.
1999.
Endotoxin-tolerant mice have mutations in Toll-like receptor 4.
J. Exp. Med.
189:615-625[Abstract/Free Full Text].
|
| 25.
|
Schwandner, R.,
R. Dziarski,
H. Wesche,
M. Rothe, and C. J. Kirschning.
1999.
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2.
J. Biol. Chem.
274:17406-17409[Abstract/Free Full Text].
|
| 26.
|
Sebastiani, D.,
G. Leveque,
L. Lariviere,
L. Laroche,
E. Skamene,
P. Gross, and D. Malo.
2000.
Cloning and characterization of the murine Toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice.
Genomics
64:230-240[CrossRef][Medline].
|
| 27.
|
Smith, P. D.,
E. N. Janoff,
M. Mosteller-Barnum,
M. Merger,
J. M. Orenstein,
J. F. Kearney, and M. F. Graham.
1997.
Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine.
J. Immunol. Methods
202:1-11[CrossRef][Medline].
|
| 28.
|
Steiner, T. S.,
J. P. Nataro,
C. E. Poteet-Smith,
J. A. Smith, and R. L. Guerrant.
2000.
Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells.
J. Clin. Investig.
105:1769-1777[Medline].
|
| 29.
|
Swantek, J. L.,
M. F. Tsen,
M. H. Cobb, and J. A. Thomas.
2000.
IL-1 receptor-associated kinase modulates host responsiveness to endotoxin.
J. Immunol.
164:4301-4306[Abstract/Free Full Text].
|
| 30.
|
Takeuchi, O.,
A. Kaufman,
K. Grote,
T. Kawai,
K. Hoshino,
M. Morr,
P. F. Muhlradt, and S. Akira.
2000.
Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
J. Immunol.
164:554-557[Abstract/Free Full Text].
|
| 31.
|
Underhill, D. M.,
A. Ozinsky,
K. D. Smith, and A. Aderem.
1999.
Toll-like receptor 2 mediates mycobacteria-induced proinflammatory signaling in macrophages.
Proc. Natl. Acad. Sci. USA
96:14459-14463[Abstract/Free Full Text].
|
| 32.
|
Underhill, D. M.,
A. Ozinsky,
A. M. Hajjar,
A. Stevens,
C. B. Wilson,
M. Bassetti, and A. Aderem.
1999.
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.
Nature
401:811-815[CrossRef][Medline].
|
| 33.
|
Wesche, H.,
W. J. Henzel,
W. Shillinglaw, and Z. Cao.
1997.
MyD88: an adaptor that recruits IRAK to the IL-1 receptor complex.
Immunity
7:837-847[CrossRef][Medline].
|
| 34.
|
Wright, S. D.,
R. A. Ramos,
P. S. Tobias,
R. J. Ulevitch, and J. C. Mathison.
1990.
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
Science
249:1431-1433[Abstract/Free Full Text].
|
| 35.
|
Wyant, T. L.,
M. K. Tanner, and M. B. Sztein.
1999.
Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes.
Infect. Immun.
67:3619-3624[Abstract/Free Full Text].
|
| 36.
|
Yamin, T., and D. K. Miller.
1997.
The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation.
J. Biol. Chem.
272:21540-21547[Abstract/Free Full Text].
|
| 37.
|
Yang, R.,
M. Mark,
A. L. Gurney, and P. J. Godowski.
1999.
Signaling events induced by lipopolysaccharide-activated Toll-like receptor 2.
J. Immunol.
163:639-643[Abstract/Free Full Text].
|
Infection and Immunity, July 2001, p. 4424-4429, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4424-4429.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kato, K., Lu, W., Kai, H., Kim, K. C.
(2007). Phosphoinositide 3-kinase is activated by MUC1 but not responsible for MUC1-induced suppression of Toll-like receptor 5 signaling. Am. J. Physiol. Lung Cell. Mol. Physiol.
293: L686-L692
[Abstract]
[Full Text]
-
Ivison, S. M., Graham, N. R., Bernales, C. Q., Kifayet, A., Ng, N., Shobab, L. A., Steiner, T. S.
(2007). Protein Kinase D Interaction with TLR5 Is Required for Inflammatory Signaling in Response to Bacterial Flagellin. J. Immunol.
178: 5735-5743
[Abstract]
[Full Text]
-
Sun, J., Fegan, P. E., Desai, A. S., Madara, J. L., Hobert, M. E.
(2007). Flagellin-induced tolerance of the Toll-like receptor 5 signaling pathway in polarized intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol.
292: G767-G778
[Abstract]
[Full Text]
-
Lu, W., Hisatsune, A., Koga, T., Kato, K., Kuwahara, I., Lillehoj, E. P., Chen, W., Cross, A. S., Gendler, S. J., Gewirtz, A. T., Kim, K. C.
(2006). Cutting Edge: Enhanced Pulmonary Clearance of Pseudomonas aeruginosa by Muc1 Knockout Mice. J. Immunol.
176: 3890-3894
[Abstract]
[Full Text]
-
Verma, A., Arora, S. K., Kuravi, S. K., Ramphal, R.
(2005). Roles of Specific Amino Acids in the N Terminus of Pseudomonas aeruginosa Flagellin and of Flagellin Glycosylation in the Innate Immune Response. Infect. Immun.
73: 8237-8246
[Abstract]
[Full Text]
-
Wright, K. J., Seed, P. C., Hultgren, S. J.
(2005). Uropathogenic Escherichia coli Flagella Aid in Efficient Urinary Tract Colonization. Infect. Immun.
73: 7657-7668
[Abstract]
[Full Text]
-
De Nardo, D., Masendycz, P., Ho, S., Cross, M., Fleetwood, A. J., Reynolds, E. C., Hamilton, J. A., Scholz, G. M.
(2005). A Central Role for the Hsp90{middle dot}Cdc37 Molecular Chaperone Module in Interleukin-1 Receptor-associated-kinase-dependent Signaling by Toll-like Receptors. J. Biol. Chem.
280: 9813-9822
[Abstract]
[Full Text]
-
West, A. P., Dancho, B. A., Mizel, S. B.
(2005). Gangliosides Inhibit Flagellin Signaling in the Absence of an Effect on Flagellin Binding to Toll-like Receptor 5. J. Biol. Chem.
280: 9482-9488
[Abstract]
[Full Text]
-
Greene, C. M., Carroll, T. P., Smith, S. G. J., Taggart, C. C., Devaney, J., Griffin, S., O'Neill, S. J., McElvaney, N. G.
(2005). TLR-Induced Inflammation in Cystic Fibrosis and Non-Cystic Fibrosis Airway Epithelial Cells. J. Immunol.
174: 1638-1646
[Abstract]
[Full Text]
-
Huang, Y., Li, T., Sane, D. C., Li, L.
(2004). IRAK1 Serves as a Novel Regulator Essential for Lipopolysaccharide-induced Interleukin-10 Gene Expression. J. Biol. Chem.
279: 51697-51703
[Abstract]
[Full Text]
-
Tsujita, T., Tsukada, H., Nakao, M., Oshiumi, H., Matsumoto, M., Seya, T.
(2004). Sensing Bacterial Flagellin by Membrane and Soluble Orthologs of Toll-like Receptor 5 in Rainbow Trout (Onchorhynchus mikiss). J. Biol. Chem.
279: 48588-48597
[Abstract]
[Full Text]
-
Lyons, S., Wang, L., Casanova, J. E., Sitaraman, S. V., Merlin, D., Gewirtz, A. T.
(2004). Salmonella typhimurium transcytoses flagellin via an SPI2-mediated vesicular transport pathway. J. Cell Sci.
117: 5771-5780
[Abstract]
[Full Text]
-
Noubir, S., Hmama, Z., Reiner, N. E.
(2004). Dual Receptors and Distinct Pathways Mediate Interleukin-1 Receptor-associated Kinase Degradation in Response to Lipopolysaccharide: INVOLVEMENT OF CD14/TLR4, CR3, AND PHOSPHATIDYLINOSITOL 3-KINASE. J. Biol. Chem.
279: 25189-25195
[Abstract]
[Full Text]
-
Didierlaurent, A., Ferrero, I., Otten, L. A., Dubois, B., Reinhardt, M., Carlsen, H., Blomhoff, R., Akira, S., Kraehenbuhl, J.-P., Sirard, J.-C.
(2004). Flagellin Promotes Myeloid Differentiation Factor 88-Dependent Development of Th2-Type Response. J. Immunol.
172: 6922-6930
[Abstract]
[Full Text]
-
Adamo, R., Sokol, S., Soong, G., Gomez, M. I., Prince, A.
(2004). Pseudomonas aeruginosa Flagella Activate Airway Epithelial Cells through asialoGM1 and Toll-Like Receptor 2 as well as Toll-Like Receptor 5. Am. J. Respir. Cell Mol. Bio.
30: 627-634
[Abstract]
[Full Text]
-
Maaser, C., Heidemann, J., von Eiff, C., Lugering, A., Spahn, T. W., Binion, D. G., Domschke, W., Lugering, N., Kucharzik, T.
(2004). Human Intestinal Microvascular Endothelial Cells Express Toll-Like Receptor 5: A Binding Partner for Bacterial Flagellin. J. Immunol.
172: 5056-5062
[Abstract]
[Full Text]
-
Murthy, K. G. K., Deb, A., Goonesekera, S., Szabo, C., Salzman, A. L.
(2004). Identification of Conserved Domains in Salmonella muenchen Flagellin That Are Essential for Its Ability to Activate TLR5 and to Induce an Inflammatory Response in Vitro. J. Biol. Chem.
279: 5667-5675
[Abstract]
[Full Text]
-
Yu, Y., Zeng, H., Lyons, S., Carlson, A., Merlin, D., Neish, A. S., Gewirtz, A. T.
(2003). TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism. Am. J. Physiol. Gastrointest. Liver Physiol.
285: G282-G290
[Abstract]
[Full Text]
-
Mizel, S. B., West, A. P., Hantgan, R. R.
(2003). Identification of a Sequence in Human Toll-like Receptor 5 Required for the Binding of Gram-negative Flagellin. J. Biol. Chem.
278: 23624-23629
[Abstract]
[Full Text]
-
Mizel, S. B., Honko, A. N., Moors, M. A., Smith, P. S., West, A. P.
(2003). Induction of Macrophage Nitric Oxide Production by Gram-Negative Flagellin Involves Signaling Via Heteromeric Toll-Like Receptor 5/Toll-Like Receptor 4 Complexes. J. Immunol.
170: 6217-6223
[Abstract]
[Full Text]
-
Means, T. K., Hayashi, F., Smith, K. D., Aderem, A., Luster, A. D.
(2003). The Toll-Like Receptor 5 Stimulus Bacterial Flagellin Induces Maturation and Chemokine Production in Human Dendritic Cells. J. Immunol.
170: 5165-5175
[Abstract]
[Full Text]
-
Jacinto, R., Hartung, T., McCall, C., Li, L.
(2002). Lipopolysaccharide- and Lipoteichoic Acid-Induced Tolerance and Cross-Tolerance: Distinct Alterations in IL-1 Receptor-Associated Kinase. J. Immunol.
168: 6136-6141
[Abstract]
[Full Text]
-
Mizel, S. B., Snipes, J. A.
(2002). Gram-negative Flagellin-induced Self-tolerance Is Associated with a Block in Interleukin-1 Receptor-associated Kinase Release from Toll-like Receptor 5. J. Biol. Chem.
277: 22414-22420
[Abstract]
[Full Text]
-
Hu, J., Jacinto, R., McCall, C., Li, L.
(2002). Regulation of IL-1 Receptor-Associated Kinases by Lipopolysaccharide. J. Immunol.
168: 3910-3914
[Abstract]
[Full Text]
-
Liaudet, L., Murthy, K. G. K., Mabley, J. G., Pacher, P., Soriano, F. G., Salzman, A. L., Szabo, C.
(2002). Comparison of Inflammation, Organ Damage, and Oxidant Stress Induced by Salmonella enterica Serovar Muenchen Flagellin and Serovar Enteritidis Lipopolysaccharide. Infect. Immun.
70: 192-198
[Abstract]
[Full Text]
-
Li, C., Wang, Y., Gao, L., Zhang, J., Shao, J., Wang, S., Feng, W., Wang, X., Li, M., Chang, Z.
(2002). Expression of Toll-like Receptors 2 and 4 and CD14 during Differentiation of HL-60 Cells Induced by Phorbol 12-Myristate 13-Acetate and 1{alpha}, 25-Dihydroxy-Vitamin D3. Cell Growth Differ.
13: 27-38
[Abstract]
[Full Text]
-
Walsh, D. E., Greene, C. M., Carroll, T. P., Taggart, C. C., Gallagher, P. M., O'Neill, S. J., McElvaney, N. G.
(2001). Interleukin-8 Up-regulation by Neutrophil Elastase Is Mediated by MyD88/IRAK/TRAF-6 in Human Bronchial Epithelium. J. Biol. Chem.
276: 35494-35499
[Abstract]
[Full Text]